14th European Congress of Clinical Microbiology and Infectious ...

Scientific Programme Monday, May 3, 2004
O290 Pertussis incidence in the Netherlands after
16:30 introduction of an acellular booster
vaccination at 4 years of age
S.C. de Greeff, J.F.P. Schellekens, F.R. Mooi,
H.E. de Melker (Bilthoven, NL)
O291 Intensified surveillance after introduction of
16:42 vaccination against meningococcal C disease
in the Netherlands
S.C. de Greeff, L. Spanjaard, M. van Deuren,
H. Ruijs, J. Dankert, A. Timen, M. de Vries,
L. Schouls, H.E. de Melker (Bilthoven,
Amsterdam, Nijmegen, Tiel, Utrecht, NL)
O292 Vaccination against hepatitis B in newborns
16:54 of HBsAg positive mothers
L. Roznovsky, I. Orsagova, I. Lochman,
L. Lukacova, A. Zjevikova, A. Sulakova,
L. Pliskova, A. Kloudova, J. Chovancik
(Ostrava, Hradec Kralove, CZ)
O293 Protective effect in monkeys following
17:06 immunisation with a live attenuated chimeric
flavivirus against tick-borne encephalitis
N.S. Pripuzova, L.V. Gmil, T.I. Dzhivanyan,
A.A. Rumyantsev, V.A. Lashkevich, G.G. Karganova
(Moscow, RUS; Bethesda, USA)
O294 HLA polymorphisms and T cell cytokine
17:18 responses to processed HLA class II measles
virus peptides: the rationale for a measles
peptide vaccine
I.G. Ovsyannikova, K.L. Johnson, R.A. Vierkant,
D.C. Muddiman, G.A. Poland (Rochester, USA)
Conference
Hall
Tropical and parasitic diseases
Chairpersons: Roxana Filip (Iasi, RO)
Christoph Hatz (Basle, CH)
O295 Post-travel related hospitalisation in Israel
15:30 S. Stienlauf, G. Segall, Y. Sidi, E. Schwartz
(Tel Hashomer, IL)
O296 Treatment of uncomplicated imported
15:42 falciparum malaria in Italy
N. Saleri, A. Matteelli, M. Gulletta, Z. Bisoffi,
R. Visonà, G. Gaiera, G. Gregis, L. Tomasoni,
F. De Iaco, F. Castelli – Lombardy Study Group
on International Health (SIRL)
O297 Retrospective study of imported malaria
15:54 diagnosed in Mallorca, Spain
M. Rotger, C. Lloret, T. Serra, S. Pons,
M.A. Vicente, A. de Lucio, J.L. Perez
(Palma de Mallorca, Madrid, E)
O298 Ultrasound guided fine needle aspiration
16:06 biopsy in the diagnosis of visceral leishmaniasis
A. Giorgio, G. de Stefano, V. Scala, G. Liorre,
A. Di Sarno, A. Sullo, P. Sorrentino (Naples, I)
O299 Short-course liposomal amphotericin B in the
16:18 treatment of infantile visceral leishmaniasis:
the Italian experience
A. Cascio, L. di Martino, P. Occorsio, R. Giacchino,
S. Catania, A.R. Gigliotti, C. Aiassa, C. Iaria,
S. Giordano, C. Colomba, V. Frasca Polara,
L. Titone, L. Gradoni, M. Gramiccia, S. Antinori
(Messina, Naples, Genoa, Rome, Palermo, Milan, I)
O300 An open, randomised controlled trial of
16:30 penicillin, doxycycline, and cefotaxime in
patients with severe leptospirosis
Y. Suputtamongkol, K. Niwatayakul, C. Suttinont,
K. Losuwanaluk, R. Limpaiboon, W. Chierakul,
V. Wuthiekanun, S. Triengrim, M. Chenchitikul,
N. White (Bangkok, Loei Province, Nakhon
Ratchasima Province, Bureerum Province,
Udornthani Province, Nondhaburi, TH)
O301 A study on some epidemiologic and
16:42 paediatric aspects of toxocarosis in Hungary
Z. Szénási, O. Bede, J. Danka, K.N. Horváth,
I. Kucsera, É. Fok, E. Orosz
(Budapest, Szeged, HUN)
O302 Serological evidence for the occurrence of
16:54 tick-borne diseases in northern Mongolia
G. Walder, E. Lkhamsuren, D. Abmed,
T. Batmunkh, D. Orth, M.P. Dierich, R. Würzner,
G. Heinz (Innsbruck, A; Ulan Bataar, MN;
Moscow, RUS; Vienna, A)
O303 The United Kingdom National External
17:06 Quality Assessment Scheme for Parasitology:
toxoplasma subschemes
M. Kettelhut, P. Chiodini, D. Ho-Yen, R. Holliman,
V. James, P. Thomas (London, Inverness,
Swansea, UK)
O304 Web-based guidelines for the evaluation of
17:18 fever in returning travellers and migrants
(www.fevertravel.ch): promotion and
appropriateness for the primary care
physician
V. D'Acremont, A. Ambresin, B. Burnand,
B. Genton (Lausanne, CH)
www.escmid.org/eccmid2004 page 53